Screening compound: C22H21ClN4O3 (J101-0302)

Screening compound: C<sub>22</sub>H<sub>21</sub>ClN<sub>4</sub>O<sub>3</sub> (J101-0302)
Screening compound: C<sub>22</sub>H<sub>21</sub>ClN<sub>4</sub>O<sub>3</sub> (J101-0302) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C22H21ClN4O3 (J101-0302)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J101-0302

Molecular Formula

C22H21ClN4O3 (C22 H21 ClN4 O3)

Compound Name

N-[2-(4-chloro-1H-indol-1-yl)ethyl]-3-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)propanamide

IUPAC name

N-[2-(4-chloro-1H-indol-1-yl)ethyl]-3-[(3R)-25-dioxo-2345-tetrahydro-1H-14-benzodiazepin-3-yl]propanamide

SMILES

O=C(CC[C@H](C(Nc1c2cccc1)=O)NC2=O)NCCn1c2cccc(Cl)c2cc1

InChI

InChI=1S/C22H21ClN4O3/c23-16-5-3-7-19-14(16)10-12-27(19)13-11-24-20(28)9-8-18-22(30)25-17-6-2-1-4-15(17)21(29)26-18/h1-7,10,12,18H,8-9,11,13H2,(H,24,28)(H,25,30)(H,26,29)/t18-/m1/s1

InChI Key

HGVPNFCYXDSEIP-GOSISDBHSA-N

MDL Number (MFCD)

C22H21ClN4O3 (J101-0302) in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

New Agro Library (44492 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
Agro:
  • Agro

References: we are preparing a list of scientific research reports with C22H21ClN4O3 (J101-0302) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C22H21ClN4O3 (J101-0302)?
Check Price and Availability of C22H21ClN4O3 (J101-0302), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C22H21ClN4O3 (J101-0302) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C22H21ClN4O3 (J101-0302)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C22H21ClN4O3 (J101-0302)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C22H21ClN4O3 (J101-0302) available by request